Economic pressures push IC device prices down as firms offer discounts
This article was originally published in Clinica
Executive Summary
The price being paid by publicly funded health services for devices used in interventional cardiology (IC) in the EU is going down. According to a report by the Millenium Research Group, IC device vendors are engaging in price undercutting and “ offering high-volume discounts or bundling deals with other products in their portfolios in order to encourage sales, resulting in price erosion”. Hospital purchasers are having to operate within set devices, and often forced to choose lower-cost devices. One solution to this is bulk purchasing where products are offered at lower cost, adding to price erosion. The practice of manufacturers offering high-volume sales for products at significant discounts is becoming more common across Europe, particularly in the Nordic countries and Spain.